rs1555800433

chr12-2567787-A-G

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 3P and 1B. PM2 PP2 BP4

The NM_000719.7(CACNA1C):c.1888A>G(p.Ile630Val) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. I630I) has been classified as Likely benign.

• Frequency: Genomes: not found (cov: 32)
• Consequence: CACNA1C NM_000719.7 missense
• Clinical Significance: Uncertain significance criteria provided, single submitter U:1
• Conservation: PhyloP100: 3.82

Genes affected

CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]

ACMG classification

Verdict is Uncertain_significance. Variant got 2 ACMG points.

• PM2: Very rare variant in population databases, with high coverage
• PP2: Missense variant where missense usually causes diseases, CACNA1C
• BP4: Computational evidence support a benign effect (MetaRNN=0.28043187).

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	MANE	UniProt
CACNA1C	NM_000719.7	c.1888A>G	p.Ile630Val	missense_variant	13/47	ENST00000399655.6
CACNA1C	NM_001167623.2	c.1888A>G	p.Ile630Val	missense_variant	13/47	ENST00000399603.6

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	TSL	MANE	Appris	UniProt
CACNA1C	ENST00000399603.6	c.1888A>G	p.Ile630Val	missense_variant	13/47	5	NM_001167623.2
CACNA1C	ENST00000399655.6	c.1888A>G	p.Ile630Val	missense_variant	13/47	1	NM_000719.7

Frequencies

GnomAD3 genomes Cov.: 32

GnomAD4 exome Cov.: 27

GnomAD4 genome Cov.: 32

ClinVar

Significance: Uncertain significance

Submissions summary: Uncertain:1

Revision: criteria provided, single submitter

Submissions by phenotype

Long QT syndrome Uncertain:1

Uncertain significance, criteria provided, single submitter

clinical testing

Invitae

May 01, 2017

This sequence change replaces isoleucine with valine at codon 630 of the CACNA1C protein (p.Ile630Val). The isoleucine residue is moderately conserved and there is a small physicochemical difference between isoleucine and valine. In summary, this variant is a novel missense change with uncertain impact on protein function. It has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may alter RNA splicing, but this prediction has not been confirmed by published transcriptional studies. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in individuals with a CACNA1C-related disease. -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
CardioboostArm	Benign	0.0000045
BayesDel_addAF	Pathogenic	0.16	D
BayesDel_noAF	Uncertain	0.0
Cadd	Uncertain	25
Dann	Benign	0.88
DEOGEN2	Benign	0.29	T;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;T;.;.;.;.;T;.
Eigen	Benign	-0.16
Eigen_PC	Benign	-0.011
FATHMM_MKL	Uncertain	0.93	D
M_CAP	Uncertain	0.12	D
MetaRNN	Benign	0.28	T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM	Uncertain	0.55	D
MutationTaster	Benign	1.0	D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
PrimateAI	Pathogenic	0.87	D
PROVEAN	Benign	-0.020	N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N
REVEL	Uncertain	0.64
Sift	Benign	1.0	T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
Sift4G	Benign	1.0	T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
Polyphen		0.95, 0.65, 0.032, 0.027, 0.026, 0.97, 0.94, 0.93, 0.83	.;P;P;B;B;B;P;D;D;B;P;P;D;P;P;D;.;D;D;.;.;.;P
Vest4		0.33
MutPred		0.61		.;Gain of catalytic residue at N635 (P = 0.0685);Gain of catalytic residue at N635 (P = 0.0685);Gain of catalytic residue at N635 (P = 0.0685);Gain of catalytic residue at N635 (P = 0.0685);Gain of catalytic residue at N635 (P = 0.0685);Gain of catalytic residue at N635 (P = 0.0685);Gain of catalytic residue at N635 (P = 0.0685);Gain of catalytic residue at N635 (P = 0.0685);Gain of catalytic residue at N635 (P = 0.0685);Gain of catalytic residue at N635 (P = 0.0685);Gain of catalytic residue at N635 (P = 0.0685);Gain of catalytic residue at N635 (P = 0.0685);Gain of catalytic residue at N635 (P = 0.0685);Gain of catalytic residue at N635 (P = 0.0685);Gain of catalytic residue at N635 (P = 0.0685);Gain of catalytic residue at N635 (P = 0.0685);Gain of catalytic residue at N635 (P = 0.0685);Gain of catalytic residue at N635 (P = 0.0685);Gain of catalytic residue at N635 (P = 0.0685);Gain of catalytic residue at N635 (P = 0.0685);Gain of catalytic residue at N635 (P = 0.0685);Gain of catalytic residue at N635 (P = 0.0685);
MVP		0.83
MPC		0.92
ClinPred		0.88	D
GERP RS		5.3
gMVP		0.86

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.16		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs1555800433; hg19: chr12-2676953;